Cleared Traditional

K113830 - VANTERA CLINICAL ANALYZER

K113830 is an FDA 510(k) clearance for VANTERA CLINICAL ANALYZER, manufactured by Liposcience. The device is a Class 1 Chemistry device with product code CDT cleared through the Traditional 510(k) pathway after a 247-day FDA review.

K113830 · Liposcience · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 2012
Decision
247d
Days
Class 1
Risk

K113830 is an FDA 510(k) clearance for the VANTERA CLINICAL ANALYZER. Classified as Lipase Hydrolysis/glycerol Kinase Enzyme, Triglycerides (product code CDT), Class I - General Controls.

Submitted by Liposcience (Raleigh, US). The FDA issued a Cleared decision on August 30, 2012 after a review of 247 days - an extended review cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1705 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Chemistry review framework, consistent with the majority of Class II 510(k) submissions.

View all Liposcience devices

FDA 510(k) Submission Details - K113830

510(k) Number K113830 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 27, 2011
Decision Date August 30, 2012
Days to Decision 247 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
159d slower than avg
Panel avg: 88d · This submission: 247d
Pathway characteristics
Predicate-based equivalence.

CDT Device Classification - Class 1, General Controls

Product Code CDT Lipase Hydrolysis/glycerol Kinase Enzyme, Triglycerides
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 862.1705
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - CDT Lipase Hydrolysis/glycerol Kinase Enzyme, Triglycerides

All 134
Devices cleared under the same product code (CDT) and FDA review panel - the closest regulatory comparables to K113830.
Triglycerides
K150819 · Randox Laboratories Limited · Aug 2015
ADVIA CHEMISTRY TRIGLYCERIDES_2 (TRIG_2) REAGENT
K133067 · Siemens Healthcare Diagnostics, Inc. · Nov 2013
VITROS CHEMISTRY PRODUCTS TRIG SLIDES
K130332 · Ortho-Clinical Diagnostics, Inc. · May 2013
OLYMPUS TRIGLYCERIDE TEST SYSTEM
K063804 · Olympus America, Inc. · Mar 2007
DIMENSION RXL MAX WITH STREAMLAB ANALYTICAL WORKCELL AND SAMPLE TRANSFER MODULE
K043546 · Dade Behring, Inc. · Jan 2005
VITALAB TRIGLYCERIDES REAGENT AND VITALAB CALIBRATOR
K034000 · Clinical Data, Inc. · Mar 2004